DUBLIN--(BUSINESS WIRE)--Regulatory News: Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and Euronext Growth operated by Euronext Dublin (MSTY.IE), today ...

Anyone living with chronic low back pain frequently has one wish on their mind: “Fix. My. Lower. Back.” Now, a new clinically proven restorative treatment option called ReActiv8 could make a ...

Chronic lower back pain is something that can dramatically affect a person’s lifestyle and wellbeing. Whilst most back pain only lasts a short while and can be treated with medication or physiotherapy ...

Mainstay Medical’s one-year study of its neurostimulation system for the treatment of chronic low back pain (CLBP) has ...

Founded in Minneapolis in 2008, Mainstay moved to Dublin in 2012. The latest funding will help it expand its ReActiv8 product in the US, Europe and Australia. Irish medtech company Mainstay Medical ...

Mainstay Medical Holdings plc, a medical device company focused on commercializing its innovative implantable Restorative Neurostimulation system, ReActiv8, for people with disabling mechanical ...

Medical device firm Mainstay Medical has sought approval to market in Australia its implantable device for chronic low back pain. The Dublin-listed company has applied to have ReActiv8, a ...

Mechanical chronic low back pain results from an injury or stress on the tissues surrounding the spine, including soft tissues, muscles, bones, and joints. Often, this type of pain is due to impaired ...